Dr. Neal-Perry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UNC Fertility
7920 ACC BLVD Unit 300
Raleigh, NC 27617Phone+1 919-908-0000Fax+1 919-966-6049
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Reproductive Endocrinology and Infertility, 2002 - 2005
- Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Obstetrics and Gynecology, 1998 - 2002
- Rutgers Robert Wood Johnson Medical SchoolClass of 1998
Certifications & Licensure
- NC State Medical License 2020 - 2026
- WA State Medical License 2014 - 2026
- NY State Medical License 2002 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Publications & Presentations
PubMed
- Sleep Timing, Sleep Timing Regularity, and Cognitive Performance in Women Entering Late Adulthood: The Study of Women's Health Across the Nation (SWAN).Leslie M Swanson, Michelle M Hood, Rebecca C Thurston, Meryl A Butters, Christopher E Kline
Sleep. 2025-02-16 - Fezolinetant effect on vasomotor symptoms due to menopause in women unsuitable for hormone therapy.Nanette Santoro, Genevieve Neal-Perry, Petra Stute, Martin Blogg, Shayna Mancuso
Current Medical Research and Opinion. 2025-02-01 - Substance use and menopausal symptoms among people with and without HIV in the US, 2008-2020.Andrea K Knittel, Brooke W Bullington, Andrew Edmonds, Lisa Rahangdale, Genevieve Neal-Perry
Menopause. 2024-10-01
Authored Content
- Religiosity and Faith in Relation to Time to Metabolic Syndrome for Hispanic Women in a Multiethnic Cohort of Women—Findings from the Study of Women’s Health Across the Nation (SWAN)March 2018
- Religiosity and Faith in Relation to Time to Metabolic Syndrome for Hispanic Women in a Multiethnic Cohort of Women—Findings from the Study of Women’s Health Across the Nation (SWAN)March 2018
Press Mentions
- Veozah (Fezolinetant) Is a New Type of Drug for Menopausal Hot FlashesMay 17th, 2023
- Results from Astellas' Pivotal Phase 3 SKYLIGHT 1™ Study of Fezolinetant for Vasomotor Symptoms Due to Menopause Published in the LancetMarch 13th, 2023
- Nonhormonal Drug Fezolinetant Found Safe for Hot Flashes in Yearlong StudyOctober 19th, 2022
- Join now to see all
Grant Support
- Advancing womens health through research: the UNC WRHR Career Development ProgramUNIV OF NORTH CAROLINA CHAPEL HILL2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: